转移性儿童甲状腺癌的遗传学特征和预后

曲以平; 侯鹏

doi:10.19401/j.cnki.1007-3639.2022.05.001

您当前的位置：

首页 >

文章列表页 >

转移性儿童甲状腺癌的遗传学特征和预后

专家述评 | 更新时间：2025-12-31

- 转移性儿童甲状腺癌的遗传学特征和预后
- Genetic characteristics and prognosis of metastatic thyroid cancer in children
- 中国癌症杂志 2022年32卷第5期页码：373-379
- 作者机构：
  
  1. 西安交通大学第一附属医院肿瘤放疗科,陕西西安 710061
  2. 西安交通大学第一附属医院内分泌代谢科,陕西西安 710061
  3. 陕西省肿瘤精准医学重点实验室,陕西西安 710061
- 作者简介：
  
  [ "曲以平（ORCID: 0000-0002-3674-9158）,博士,助理研究员 E-mail: 15398036489@163.com" ]
  [ "侯鹏,教授,博士研究生导师,西安交通大学第一附属医院内分泌代谢科副主任,西安交通大学第九批“腾飞”特聘教授及第一批“青年拔尖人才”,陕西省中青年科技创新领军人才,陕西省肿瘤精准医学重点实验室副主任。2005—2009年在美国约翰·霍普金斯大学医学院从事博士后研究工作,主要研究方向为内分泌系统肿瘤。2009年9月受聘于西安交通大学第一附属医院,并获得光华基金资助（光华特聘教授）,2010年入选教育部新世纪优秀人才支持计划。近年来,主持国家自然科学基金6项、973计划子课题1项、省部级项目4项,以第一作者或通信作者在SCI收录期刊上发表论文95篇（其中在影响因子>10的期刊上发表19篇,H指数为40）,获得陕西省科学技术奖二等奖及中华医学科技奖三等奖各1项。" ]
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2022.05.001
  中图分类号： R736.1
- 收稿：2022-03-14，
  
  修回：2022-04-29，
  
  纸质出版：2022-05-30
- 稿件说明：
移动端阅览
曲以平, 侯鹏. 转移性儿童甲状腺癌的遗传学特征和预后[J]. 中国癌症杂志, 2022,32(5):373-379.

Yiping QU, Peng HOU. Genetic characteristics and prognosis of metastatic thyroid cancer in children[J]. China Oncology, 2022, 32(5): 373-379.
曲以平, 侯鹏. 转移性儿童甲状腺癌的遗传学特征和预后[J]. 中国癌症杂志, 2022,32(5):373-379. DOI： 10.19401/j.cnki.1007-3639.2022.05.001.

Yiping QU, Peng HOU. Genetic characteristics and prognosis of metastatic thyroid cancer in children[J]. China Oncology, 2022, 32(5): 373-379. DOI： 10.19401/j.cnki.1007-3639.2022.05.001.

摘要

甲状腺癌的发病率随着年龄的增长而增加

虽然儿童甲状腺癌的发病率远低于成人

但在世界范围内甲状腺癌已经成为0~14岁儿童第5大常见癌症以及青少年最常见的癌症。不同于成人患者

目前普遍认为儿童甲状腺癌发病率的增加更有可能是基因或环境因素所致

并且儿童甲状腺癌在发病时往往更趋近于晚期

其复发率也远高于成人甲状腺癌

但是儿童甲状腺癌的分子病理学特征与肿瘤转移的关系仍有待进一步明确。本文将结合国内外研究进行综述

重点讨论转移性儿童甲状腺癌的遗传学特征

为研究者和临床医师针对儿童甲状腺癌的基础研究和肿瘤防治提供参考。

Abstract

The incidence rate of thyroid cancer increases with age. Although the incidence rate of thyroid cancer in children is far lower than in adults

thyroid cancer has become the fifth most common cancer among children aged 0-14 and the most common cancer among adolescents worldwide. Unlike thyroid cancer in adults

the increase in the incidence of thyroid cancer in children is more likely to be caused by genetic or environmental factors. Moreover

thyroid cancer in children tends to be late stage

and the recurrence rate is much higher than in adults. However

the relationship between molecular pathological characteristics and metastasis of thyroid cancer in children still needs to be further clarified. This review focused on the genetic changes of metastatic thyroid cancer in children in order to provide the reference for researchers and clinicians to better understand basic research

prevention and treatment of thyroid cancer in children.

关键词

Keywords

references

PAULSON V A , RUDZINSKI E R , HAWKINS D S . Thyroid cancer in the pediatric population [J ] . Genes , 2019 , 10 ( 9 ): 723 . DOI: 10.3390/genes10090723 http://doi.org/10.3390/genes10090723 https://www.mdpi.com/2073-4425/10/9/723 https://www.mdpi.com/2073-4425/10/9/723

HANLEY P , LORD K , BAUER A J . Thyroid disorders in children and adolescents: a review [J ] . JAMA Pediatr , 2016 , 170 ( 10 ): 1008 - 1019 . DOI: 10.1001/jamapediatrics.2016.0486 http://doi.org/10.1001/jamapediatrics.2016.0486 http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/jamapediatrics.2016.0486 http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/jamapediatrics.2016.0486

BAUER A J . Pediatric thyroid cancer: genetics, therapeutics and outcome [J ] . Endocrinol Metab Clin North Am , 2020 , 49 ( 4 ): 589 - 611 . DOI: 10.1016/j.ecl.2020.08.001 http://doi.org/10.1016/j.ecl.2020.08.001 https://linkinghub.elsevier.com/retrieve/pii/S0889852920300621 https://linkinghub.elsevier.com/retrieve/pii/S0889852920300621

LUZÓN-TORO B , FERNÁNDEZ R , VILLALBA-BENITO L , et al . Influencers on thyroid cancer onset: molecular genetic basis [J ] . Genes , 2019 , 10 ( 11 ): 913 . DOI: 10.3390/genes10110913 http://doi.org/10.3390/genes10110913 https://www.mdpi.com/2073-4425/10/11/913 https://www.mdpi.com/2073-4425/10/11/913

CHAN C M , YOUNG J , PRAGER J , et al . Pediatric thyroid cancer [J ] . Adv Pediatr , 2017 , 64 ( 1 ): 171 - 190 . DOI: 10.1016/j.yapd.2017.03.007 http://doi.org/10.1016/j.yapd.2017.03.007 https://linkinghub.elsevier.com/retrieve/pii/S0065310117300075 https://linkinghub.elsevier.com/retrieve/pii/S0065310117300075

PARISI M T , KHALATBARI H , PARIKH S R , et al . Initial treatment of pediatric differentiated thyroid cancer: a review of the current risk-adaptive approach [J ] . Pediatr Radiol , 2019 , 49 ( 11 ): 1391 - 1403 . DOI: 10.1007/s00247-019-04457-7 http://doi.org/10.1007/s00247-019-04457-7 https://doi.org/10.1007/s00247-019-04457-7 https://doi.org/10.1007/s00247-019-04457-7

CHESOVER A D , VALI R , HEMMATI S H , et al . Lung metastasis in children with differentiated thyroid cancer: factors associated with diagnosis and outcomes of therapy [J ] . Thyroid , 2021 , 31 ( 1 ): 50 - 60 . DOI: 10.1089/thy.2020.0002 http://doi.org/10.1089/thy.2020.0002 https://www.liebertpub.com/doi/10.1089/thy.2020.0002 https://www.liebertpub.com/doi/10.1089/thy.2020.0002

KIRATLI P O , VOLKAN-SALANCI B , GÜNAY E C , et al . Thyroid cancer in pediatric age group: an institutional experience and review of the literature [J ] . J Pediatr Hematol Oncol , 2013 , 35 ( 2 ): 93 - 97 . DOI: 10.1097/MPH.0b013e3182755d9e http://doi.org/10.1097/MPH.0b013e3182755d9e https://journals.lww.com/00043426-201303000-00003 https://journals.lww.com/00043426-201303000-00003

DERMODY S , WALLS A , HARLEY E H Jr . Pediatric thyroid cancer: an update from the SEER database 2007-2012 [J ] . Int J Pediatr Otorhinolaryngol , 2016 , 89 : 121 - 126 . DOI: 10.1016/j.ijporl.2016.08.005 http://doi.org/10.1016/j.ijporl.2016.08.005 https://linkinghub.elsevier.com/retrieve/pii/S0165587616302609 https://linkinghub.elsevier.com/retrieve/pii/S0165587616302609

CHRISTISON-LAGAY E , BAERTSCHIGER R M . Management of differentiated thyroid carcinoma in pediatric patients [J ] . Surg Oncol Clin N Am , 2021 , 30 ( 2 ): 235 - 251 . DOI: 10.1016/j.soc.2020.11.013 http://doi.org/10.1016/j.soc.2020.11.013 https://linkinghub.elsevier.com/retrieve/pii/S1055320720301083 https://linkinghub.elsevier.com/retrieve/pii/S1055320720301083

LEE Y A , JUNG H W , KIM H Y , et al . Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years [J ] . J Clin Endocrinol Metab , 2015 , 100 ( 4 ): 1619 - 1629 . DOI: 10.1210/jc.2014-3647 http://doi.org/10.1210/jc.2014-3647 https://academic.oup.com/jcem/article/100/4/1619/2815135 https://academic.oup.com/jcem/article/100/4/1619/2815135

CORDIOLI M I , MORAES L , CURY A N , et al . Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma? [J ] . Endocr Relat Cancer , 2015 , 22 ( 6 ): R311 - R324 . DOI: 10.1530/ERC-15-0381 http://doi.org/10.1530/ERC-15-0381 https://erc.bioscientifica.com/view/journals/erc/22/6/R311.xml https://erc.bioscientifica.com/view/journals/erc/22/6/R311.xml

O’GORMAN C S , HAMILTON J , RACHMIEL M , et al . Thyroid cancer in childhood: a retrospective review of childhood course [J ] . Thyroid , 2010 , 20 ( 4 ): 375 - 380 . DOI: 10.1089/thy.2009.0386 http://doi.org/10.1089/thy.2009.0386 https://www.liebertpub.com/doi/10.1089/thy.2009.0386 https://www.liebertpub.com/doi/10.1089/thy.2009.0386

NIKIFOROV Y E . Radiation-induced thyroid cancer: what we have learned from Chernobyl [J ] . Endocr Pathol , 2006 , 17 ( 4 ): 307 - 317 . DOI: 10.1007/s12022-006-0001-5 http://doi.org/10.1007/s12022-006-0001-5 https://link.springer.com/10.1007/s12022-006-0001-5 https://link.springer.com/10.1007/s12022-006-0001-5

FEINMESSER R , LUBIN E , SEGAL K , et al . Carcinoma of the thyroid in children: a review [J ] . J Pediatr Endocrinol Metab , 1997 , 10 ( 6 ): 561 - 568 .

AL-QURAYSHI Z , HAUCH A , SRIVASTAV S , et al . A national perspective of the risk, presentation, and outcomes of pediatric thyroid cancer [J ] . JAMA Otolaryngol Head Neck Surg , 2016 , 142 ( 5 ): 472 - 478 . DOI: 10.1001/jamaoto.2016.0104 http://doi.org/10.1001/jamaoto.2016.0104 http://archotol.jamanetwork.com/article.aspx?doi=10.1001/jamaoto.2016.0104 http://archotol.jamanetwork.com/article.aspx?doi=10.1001/jamaoto.2016.0104

RUSSO M , MALANDRINO P , MOLETI M , et al . Differentiated thyroid cancer in children: heterogeneity of predictive risk factors [J ] . Pediatr Blood Cancer , 2018 , 65 ( 9 ): e27226 . DOI: 10.1002/pbc.27226 http://doi.org/10.1002/pbc.27226 https://onlinelibrary.wiley.com/doi/10.1002/pbc.27226 https://onlinelibrary.wiley.com/doi/10.1002/pbc.27226

NGO D Q , LE D T , NGO Q X , et al . Risk factors for lateral lymph node metastasis of papillary thyroid carcinoma in children [J ] . J Pediatr Surg , 2022

BAUMGARTEN H , JENKS C M , ISAZA A , et al . Bilateral papillary thyroid cancer in children: risk factors and frequency of postoperative diagnosis [J ] . J Pediatr Surg , 2020 , 55 ( 6 ): 1117 - 1122 . DOI: 10.1016/j.jpedsurg.2020.02.040 http://doi.org/10.1016/j.jpedsurg.2020.02.040 https://linkinghub.elsevier.com/retrieve/pii/S0022346820301688 https://linkinghub.elsevier.com/retrieve/pii/S0022346820301688

NGO D Q , NGO Q X , VAN LE Q . Pediatric thyroid cancer: risk factors for central lymph node metastasis in patients with cN 0 papillary carcinoma [J ] . Int J Pediatr Otorhinolaryngol , 2020 , 133 : 110000 . DOI: 10.1016/j.ijporl.2020.110000 http://doi.org/10.1016/j.ijporl.2020.110000 https://linkinghub.elsevier.com/retrieve/pii/S0165587620301439 https://linkinghub.elsevier.com/retrieve/pii/S0165587620301439

RUBINSTEIN J C , HERRICK-REYNOLDS K , DINAUER C , et al . Recurrence and complications in pediatric and adolescent papillary thyroid cancer in a high-volume practice [J ] . J Surg Res , 2020 , 249 : 58 - 66 . DOI: 10.1016/j.jss.2019.12.002 http://doi.org/10.1016/j.jss.2019.12.002 https://linkinghub.elsevier.com/retrieve/pii/S0022480419308285 https://linkinghub.elsevier.com/retrieve/pii/S0022480419308285

KIM J , SUN Z F , ADAM M A , et al . Predictors of nodal metastasis in pediatric differentiated thyroid cancer [J ] . J Pediatr Surg , 2017 , 52 ( 1 ): 120 - 123 . DOI: 10.1016/j.jpedsurg.2016.10.033 http://doi.org/10.1016/j.jpedsurg.2016.10.033 https://linkinghub.elsevier.com/retrieve/pii/S0022346816304948 https://linkinghub.elsevier.com/retrieve/pii/S0022346816304948

LIU Z M , HU D , HUANG Y H , et al . Factors associated with distant metastasis in pediatric thyroid cancer: evaluation of the SEER database [J ] . Endocr Connect , 2019 , 8 ( 2 ): 78 - 85 . DOI: 10.1530/EC-18-0441 http://doi.org/10.1530/EC-18-0441 https://ec.bioscientifica.com/view/journals/ec/8/2/EC-18-0441.xml https://ec.bioscientifica.com/view/journals/ec/8/2/EC-18-0441.xml

SHUKLA N , OSAZUWA-PETERS N , MEGWALU U C . Association between age and nodal metastasis in papillary thyroid carcinoma [J ] . Otolaryngol Head Neck Surg , 2021 , 165 ( 1 ): 43 - 49 . DOI: 10.1177/0194599820966995 http://doi.org/10.1177/0194599820966995 http://journals.sagepub.com/doi/10.1177/0194599820966995 http://journals.sagepub.com/doi/10.1177/0194599820966995

TANG A L , KLOOS R T , AUNINS B , et al . Pathologic features associated with molecular subtypes of well-differentiated thyroid cancer [J ] . Endocr Pract , 2021 , 27 ( 3 ): 206 - 211 . DOI: 10.1016/j.eprac.2020.09.003 http://doi.org/10.1016/j.eprac.2020.09.003 https://linkinghub.elsevier.com/retrieve/pii/S1530891X20483661 https://linkinghub.elsevier.com/retrieve/pii/S1530891X20483661

GALUPPINI F , VIANELLO F , CENSI S , et al . Differentiated thyroid carcinoma in pediatric age: genetic and clinical scenario [J ] . Front Endocrinol (Lausanne) , 2019 , 10 : 552 . DOI: 10.3389/fendo.2019.00552 http://doi.org/10.3389/fendo.2019.00552 https://www.frontiersin.org/article/10.3389/fendo.2019.00552/full https://www.frontiersin.org/article/10.3389/fendo.2019.00552/full

IWADATE M , MITSUTAKE N , MATSUSE M , et al . The clinicopathological results of thyroid cancer with BRAF V600E mutation in the young population of fukushima [J ] . J Clin Endocrinol Metab , 2020 , 105 ( 12 ): dgaa573 .

DECAUSSIN-PETRUCCI M , DELADOËY J , HAFDI-NEJJARI Z , et al . Expression of CD133 in differentiated thyroid cancer of young patients [J ] . J Clin Pathol , 2015 , 68 ( 6 ): 434 - 440 . DOI: 10.1136/jclinpath-2014-202625 http://doi.org/10.1136/jclinpath-2014-202625 http://jcp.bmj.com/lookup/doi/10.1136/jclinpath-2014-202625 http://jcp.bmj.com/lookup/doi/10.1136/jclinpath-2014-202625

CORDIOLI M I C V , MORAES L , CARVALHEIRA G , et al . AGK - BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma [J ] . Cancer Med , 2016 , 5 ( 7 ): 1535 - 1541 . DOI: 10.1002/cam4.698 http://doi.org/10.1002/cam4.698 https://onlinelibrary.wiley.com/doi/10.1002/cam4.698 https://onlinelibrary.wiley.com/doi/10.1002/cam4.698

ALZAHRANI A S , ALSWAILEM M , ALSWAILEM A A , et al . Genetic alterations in pediatric thyroid cancer using a comprehensive childhood cancer gene panel [J ] . J Clin Endocrinol Metab , 2020 , 105 ( 10 ): dgaa389 .

ELISEI R , ROMEI C , VORONTSOVA T , et al . RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults [J ] . J Clin Endocrinol Metab , 2001 , 86 ( 7 ): 3211 - 3216 .

ZEINDL-EBERHART E , LIEBMANN S , JUNGBLUT P R , et al . Influence of RET/PTC1 and RET/PTC3 oncoproteins in radiation-induced papillary thyroid carcinomas on amounts of cytoskeletal protein species [J ] . Amino Acids , 2011 , 41 ( 2 ): 415 - 425 . DOI: 10.1007/s00726-010-0733-x http://doi.org/10.1007/s00726-010-0733-x http://link.springer.com/10.1007/s00726-010-0733-x http://link.springer.com/10.1007/s00726-010-0733-x

MOSTOUFI-MOAB S , LABOURIER E , SULLIVAN L , et al . Molecular testing for oncogenic gene alterations in pediatric thyroid lesions [J ] . Thyroid , 2018 , 28 ( 1 ): 60 - 67 . DOI: 10.1089/thy.2017.0059 http://doi.org/10.1089/thy.2017.0059 https://www.liebertpub.com/doi/10.1089/thy.2017.0059 https://www.liebertpub.com/doi/10.1089/thy.2017.0059

FRANCO A T , RICARTE-FILHO J C , ISAZA A , et al . Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers [J ] . J Clin Oncol , 2022 , 40 ( 10 ): 1081 - 1090 .

SASSOLAS G , HAFDI-NEJJARI Z , FERRARO A , et al . Oncogenic alterations in papillary thyroid cancers of young patients [J ] . Thyroid , 2012 , 22 ( 1 ): 17 - 26 . DOI: 10.1089/thy.2011.0215 http://doi.org/10.1089/thy.2011.0215 https://www.liebertpub.com/doi/10.1089/thy.2011.0215 https://www.liebertpub.com/doi/10.1089/thy.2011.0215

OISHI N , KONDO T , NAKAZAWA T , et al . Frequent BRAF V600E and absence of TERT promoter mutations characterize sporadic pediatric papillary thyroid carcinomas in Japan [J ] . Endocr Pathol , 2017 , 28 ( 2 ): 103 - 111 . DOI: 10.1007/s12022-017-9470-y http://doi.org/10.1007/s12022-017-9470-y https://doi.org/10.1007/s12022-017-9470-y https://doi.org/10.1007/s12022-017-9470-y

ONDER S , OZTURK SARI S , YEGEN G , et al . Classic architecture with multicentricity and local recurrence, and absence of TERT promoter mutations are correlates of BRAF (V600E) harboring pediatric papillary thyroid carcinomas [J ] . Endocr Pathol , 2016 , 27 ( 2 ): 153 - 161 . DOI: 10.1007/s12022-016-9420-0 http://doi.org/10.1007/s12022-016-9420-0 http://link.springer.com/10.1007/s12022-016-9420-0 http://link.springer.com/10.1007/s12022-016-9420-0

OTSUBO R , MUSSAZHANOVA Z , AKAZAWA Y , et al . Sporadic pediatric papillary thyroid carcinoma harboring the ETV 6/ NTRK 3 fusion oncogene in a 7-year-old Japanese girl: a case report and review of literature [J ] . J Pediatr Endocrinol Metab , 2018 , 31 ( 4 ): 461 - 467 . DOI: 10.1515/jpem-2017-0292 http://doi.org/10.1515/jpem-2017-0292 https://www.degruyter.com/document/doi/10.1515/jpem-2017-0292/html https://www.degruyter.com/document/doi/10.1515/jpem-2017-0292/html

SCOUTEN W T , PATEL A , TERRELL R , et al . Cytoplasmic localization of the paired box gene, Pax -8, is found in pediatric thyroid cancer and may be associated with a greater risk of recurrence [J ] . Thyroid , 2004 , 14 ( 12 ): 1037 - 1046 . DOI: 10.1089/thy.2004.14.1037 http://doi.org/10.1089/thy.2004.14.1037 https://www.liebertpub.com/doi/10.1089/thy.2004.14.1037 https://www.liebertpub.com/doi/10.1089/thy.2004.14.1037

STOSIC A , FULIGNI F , ANDERSON N D , et al . Diverse oncogenic fusions and distinct gene expression patterns define the genomic landscape of pediatric papillary thyroid carcinoma [J ] . Cancer Res , 2021 , 81 ( 22 ): 5625 - 5637 . DOI: 10.1158/0008-5472.CAN-21-0761 http://doi.org/10.1158/0008-5472.CAN-21-0761 https://aacrjournals.org/cancerres/article/81/22/5625/670509/Diverse-Oncogenic-Fusions-and-Distinct-Gene https://aacrjournals.org/cancerres/article/81/22/5625/670509/Diverse-Oncogenic-Fusions-and-Distinct-Gene

FRANCO A T , LABOURIER E , ABLORDEPPEY K K , et al . miRNA expression can classify pediatric thyroid lesions and increases the diagnostic yield of mutation testing [J ] . Pediatr Blood Cancer , 2020 , 67 ( 6 ): e28276 .

ELOY C , SANTOS J , SOARES P , et al . Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma [J ] . Virchows Arch , 2011 , 459 ( 6 ): 595 - 605 . DOI: 10.1007/s00428-011-1161-3 http://doi.org/10.1007/s00428-011-1161-3 http://link.springer.com/10.1007/s00428-011-1161-3 http://link.springer.com/10.1007/s00428-011-1161-3

SHIMURA K , SHIBATA H , MIZUNO Y , et al . Rapid growth and early metastasis of papillary thyroid carcinoma in an adolescent girl with Graves' disease [J ] . Horm Res Paediatr , 2019 , 91 ( 3 ): 210 - 215 . DOI: 10.1159/000491102 http://doi.org/10.1159/000491102 https://www.karger.com/Article/FullText/491102 https://www.karger.com/Article/FullText/491102

CORDIOLI M I C V , MORAES L , ALVES M T , et al . Thyroid-specific genes expression uncovered age-related differences in pediatric thyroid carcinomas [J ] . Int J Endocrinol , 2016 , 2016 : 1956740 .

JARZAB B , HANDKIEWICZ-JUNAK D . Differentiated thyroid cancer in children and adults: same or distinct disease? [J ] . Hormones (Athens) , 2007 , 6 ( 3 ): 200 - 209 .

LAN X B , BAO H , GE X Y , et al . Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis [J ] . Cancer Sci , 2020 , 111 ( 6 ): 2163 - 2173 . DOI: 10.1111/cas.14389 http://doi.org/10.1111/cas.14389 https://onlinelibrary.wiley.com/doi/10.1111/cas.14389 https://onlinelibrary.wiley.com/doi/10.1111/cas.14389

ZANELLA A B , SCHEFFEL R S , NAVA C F , et al . Dynamic risk stratification in the follow-up of children and adolescents with differentiated thyroid cancer [J ] . Thyroid , 2018 , 28 ( 10 ): 1285 - 1292 . DOI: 10.1089/thy.2018.0075 http://doi.org/10.1089/thy.2018.0075 https://www.liebertpub.com/doi/10.1089/thy.2018.0075 https://www.liebertpub.com/doi/10.1089/thy.2018.0075

NIKIFOROV Y E . Thyroid carcinoma: molecular pathways and therapeutic targets [J ] . Mod Pathol , 2008 , 21 ( Suppl 2 ): S37 - S43 . DOI: 10.1038/modpathol.2008.10 http://doi.org/10.1038/modpathol.2008.10 https://doi.org/10.1038/modpathol.2008.10 https://doi.org/10.1038/modpathol.2008.10

DINAUER C A , BREUER C , RIVKEES S A . Differentiated thyroid cancer in children: diagnosis and management [J ] . Curr Opin Oncol , 2008 , 20 ( 1 ): 59 - 65 . DOI: 10.1097/CCO.0b013e3282f30220 http://doi.org/10.1097/CCO.0b013e3282f30220 https://journals.lww.com/00001622-200801000-00009 https://journals.lww.com/00001622-200801000-00009

FRANCIS G L , WAGUESPACK S G , BAUER A J , et al . Management guidelines for children with thyroid nodules and differentiated thyroid cancer [J ] . Thyroid , 2015 , 25 ( 7 ): 716 - 759 . DOI: 10.1089/thy.2014.0460 http://doi.org/10.1089/thy.2014.0460 https://www.liebertpub.com/doi/10.1089/thy.2014.0460 https://www.liebertpub.com/doi/10.1089/thy.2014.0460

SUBBIAH V , HU M I , WIRTH L J , et al . Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study [J ] . Lancet Diabetes Endocrinol , 2021 , 9 ( 8 ): 491 - 501 . DOI: 10.1016/S2213-8587(21)00120-0 http://doi.org/10.1016/S2213-8587(21)00120-0 https://linkinghub.elsevier.com/retrieve/pii/S2213858721001200 https://linkinghub.elsevier.com/retrieve/pii/S2213858721001200

BRADFORD D , LARKINS E , MUSHTI S L , et al . FDA approval summary: selpercatinib for the treatment of lung and thyroid cancers with RET gene mutations or fusions [J ] . Clin Cancer Res , 2021 , 27 ( 8 ): 2130 - 2135 . DOI: 10.1158/1078-0432.CCR-20-3558 http://doi.org/10.1158/1078-0432.CCR-20-3558 https://aacrjournals.org/clincancerres/article/27/8/2130/672051/FDA-Approval-Summary-Selpercatinib-for-the https://aacrjournals.org/clincancerres/article/27/8/2130/672051/FDA-Approval-Summary-Selpercatinib-for-the

BROSE M S , NUTTING C M , JARZAB B , et al . Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial [J ] . Lancet , 2014 , 384 ( 9940 ): 319 - 328 . DOI: 10.1016/S0140-6736(14)60421-9 http://doi.org/10.1016/S0140-6736(14)60421-9 https://linkinghub.elsevier.com/retrieve/pii/S0140673614604219 https://linkinghub.elsevier.com/retrieve/pii/S0140673614604219

FENG G L , LUO Y , ZHANG Q , et al . Sorafenib and radioiodine-refractory differentiated thyroid cancer (RR-DTC): a systematic review and meta-analysis [J ] . Endocrine , 2020 , 68 ( 1 ): 56 - 63 . DOI: 10.1007/s12020-019-02167-6 http://doi.org/10.1007/s12020-019-02167-6 https://doi.org/10.1007/s12020-019-02167-6 https://doi.org/10.1007/s12020-019-02167-6

HIGUCHI Y , MOTOKI T , ISHIDA H , et al . Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report [J ] . BMC Cancer , 2017 , 17 ( 1 ): 775 . DOI: 10.1186/s12885-017-3782-7 http://doi.org/10.1186/s12885-017-3782-7 https://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3782-7 https://bmccancer.biomedcentral.com/articles/10.1186/s12885-017-3782-7

WELLS S A Jr , ROBINSON B G , GAGEL R F , et al . Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase Ⅲ trial [J ] . J Clin Oncol , 2012 , 30 ( 2 ): 134 - 141 .

GRANDE E , KREISSL M C , FILETTI S , et al . Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies [J ] . Adv Ther , 2013 , 30 ( 11 ): 945 - 966 . DOI: 10.1007/s12325-013-0069-5 http://doi.org/10.1007/s12325-013-0069-5 http://link.springer.com/10.1007/s12325-013-0069-5 http://link.springer.com/10.1007/s12325-013-0069-5

FOX E , WIDEMANN B C , CHUK M K , et al . Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma [J ] . Clin Cancer Res , 2013 , 19 ( 15 ): 4239 - 4248 . DOI: 10.1158/1078-0432.CCR-13-0071 http://doi.org/10.1158/1078-0432.CCR-13-0071 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-13-0071 http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-13-0071

FERRARI S M , ELIA G , RAGUSA F , et al . Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer [J ] . Expert Opin Investig Drugs , 2021 , 30 ( 9 ): 913 - 921 . DOI: 10.1080/13543784.2021.1972971 http://doi.org/10.1080/13543784.2021.1972971 https://www.tandfonline.com/doi/full/10.1080/13543784.2021.1972971 https://www.tandfonline.com/doi/full/10.1080/13543784.2021.1972971

MATRONE A , PRETE A , NERVO A , et al . Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer [J ] . J Endocrinol Invest , 2021 , 44 ( 10 ): 2139 - 2151 . DOI: 10.1007/s40618-020-01491-3 http://doi.org/10.1007/s40618-020-01491-3 https://doi.org/10.1007/s40618-020-01491-3 https://doi.org/10.1007/s40618-020-01491-3

MAHAJAN P , DAWRANT J , KHERADPOUR A , et al . Response to lenvatinib in children with papillary thyroid carcinoma [J ] . Thyroid , 2018 , 28 ( 11 ): 1450 - 1454 . DOI: 10.1089/thy.2018.0064 http://doi.org/10.1089/thy.2018.0064 https://www.liebertpub.com/doi/10.1089/thy.2018.0064 https://www.liebertpub.com/doi/10.1089/thy.2018.0064

GASPAR N , CAMPBELL-HEWSON Q , MELCON S G , et al . Phase Ⅰ/Ⅱ study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050) [J ] . ESMO Open , 2021 , 6 ( 5 ): 100250 . DOI: 10.1016/j.esmoop.2021.100250 http://doi.org/10.1016/j.esmoop.2021.100250 https://linkinghub.elsevier.com/retrieve/pii/S2059702921002118 https://linkinghub.elsevier.com/retrieve/pii/S2059702921002118

ZHANG Y C , DENG X Z , DING Z , et al . Preoperative neoadjuvant targeted therapy with apatinib for inoperable differentiated thyroid cancer: a case report [J ] . Medicine , 2021 , 100 ( 12 ): e25191 . DOI: 10.1097/MD.0000000000025191 http://doi.org/10.1097/MD.0000000000025191 https://journals.lww.com/10.1097/MD.0000000000025191 https://journals.lww.com/10.1097/MD.0000000000025191

浏览量

2684

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

SMARCA4缺失型肺恶性肿瘤的临床病理学特征及患者预后分析

87例唾液腺导管癌患者的治疗策略与预后分析：一项回顾性队列研究

放射性淋巴细胞减少对局限期小细胞肺癌患者预后的影响：一项队列研究

肢端型黑色素瘤组织中MITF的表达及其与临床、病理学特征及预后的相关性研究

¹⁸F-FDG PET/CT代谢参数对接受CAR-T治疗的弥漫大B细胞淋巴瘤患者预后价值的队列研究